The Medicines Company (MDCO) Signs Agreement to Acquire ProFibrix for Up to $10 Million
6/4/2013 6:50:39 AM
More...
|
The Medicines Company (MDCO)'s RECOTHROM Becomes the First and Only Topical Thrombin Indicated for Use in Children Greater Than or Equal to One Month of Age
5/10/2013 10:37:27 AM
More...
|
The Medicines Company (MDCO) Reports First Quarter 2013 Financial Results
4/24/2013 10:04:31 AM
More...
|
The Medicines Company (MDCO) to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013
4/11/2013 10:48:03 AM
More...
|
The Medicines Company (MDCO) Drug More Effective Than Plavix in Coronary Procedures
3/11/2013 8:00:30 AM
More...
|
The Medicines Company (MDCO) to Host Cangrelor Webcast on Sunday, March 10, 2013
3/8/2013 8:48:08 AM
More...
|
The Medicines Company (MDCO) to Participate in RBC Capital Markets Healthcare Conference
2/25/2013 9:55:56 AM
More...
|
The Medicines Company (MDCO) Reports Fourth Quarter and Full Year 2012 Financial Results
2/20/2013 9:34:26 AM
More...
|
The Medicines Company (MDCO) to Announce Fourth Quarter and Full Year 2012 Financial Results on Wednesday, February 20, 2013
2/13/2013 10:13:19 AM
More...
|
The Medicines Company (MDCO) and Bristol-Myers Squibb Company (BMY) Begin Global Alliance for Recothrom®
2/8/2013 9:35:19 AM
More...
|
|